Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) EBT Margin (2016 - 2025)

GeoVax Labs' EBT Margin history spans 15 years, with the latest figure at 630.05% for Q2 2025.

  • Quarterly results put EBT Margin at 630.05% for Q2 2025, up 105417.0% from a year ago — trailing twelve months through Dec 2025 was 862.34% (down 23035.0% YoY), and the annual figure for FY2025 was 862.34%, down 23035.0%.
  • EBT Margin for Q2 2025 was 630.05% at GeoVax Labs, down from 327.31% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 208.48% in Q3 2024 to a low of 8331.01% in Q4 2021.
  • The 4-year median for EBT Margin is 1549.78% (2024), against an average of 2480.75%.
  • The sharpest move saw EBT Margin tumbled -779985bps in 2021, then surged 105417bps in 2025.
  • Year by year, EBT Margin stood at 8331.01% in 2021, then soared by 64bps to 2977.6% in 2022, then surged by 68bps to 955.87% in 2024, then skyrocketed by 34bps to 630.05% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 630.05%, 327.31%, and 955.87% for Q2 2025, Q1 2025, and Q4 2024 respectively.